Innate Immunity & Hemorrhagic Fever Viruses
Innate Immunity & Hemorrhagic Fever Viruses
批准号:
7645348
负责人:
Robert William Finberg
金额:
$68.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2009-02-28
关键词:
AcuteAffectAntigen PresentationArenavirusB-LymphocytesBiologyBioterrorismBlood ProteinsCD14 geneCell LineCellsCessation of lifeChemicalsCollaborationsDataDevelopmentDiseaseDoseEbola virusEngineeringEventFeverFilovirusFunctional disorderGlycoproteinsHumanHuman Cell LineHypotensionIL8 geneImmune responseImmune systemImmunityIn VitroIndividualInfectionInflammatoryInflammatory Response PathwayKnockout MiceLeadLeukopeniaLymphocytic choriomeningitis virusMediatingMeningitisMorbidity - disease rateMusNatural ImmunityPathogenesisPattern RecognitionPattern recognition receptorPhasePreclinical Drug EvaluationProductionProteinsRateReporterRoleRunningScreening procedureSepsisSeriesShockSignal Transduction PathwayT-LymphocyteTLR1 geneTLR3 geneTLR4 geneTLR6 geneTestingTherapeuticThrombocytopeniaToll-Like Receptor 2Toll-like receptorsVaccinesVariantViral Hemorrhagic FeversViral ProteinsVirusVirus DiseasesWorkacquired immunitycytokinehemorrhagic fever virusin vivomacrophagemortalitynovelnovel therapeuticsreceptorresearch studyresponsesmall moleculesmall molecule libraries
中文摘要
这个项目将研究先天免疫系统在病毒病理生理学中的作用。
出血热。将研究两种可能导致生物恐怖主义的病毒:1)埃博拉病毒,一种
丝状病毒,引起以发烧、白细胞减少、休克和死亡为特征的急性疾病,以及2)
淋巴细胞性脉络膜脑膜炎病毒LCMV是一种引起疾病的病毒,其特征是
小鼠的白细胞减少和血小板减少,以及人类的脑膜炎。与高死亡率相关的
埃博拉病毒感染已被证明与病毒感染后细胞因子的释放直接相关
巨噬细胞感染。埃博拉病毒诱导这种细胞因子反应的机制将被定义
将对化合物进行筛选,以确定其抑制这一活性的能力。初步数据显示,
Toll样受体2(TLR-2)和CD14在LCMV细胞因子应答中的作用。TLR-2和CD14是模式
识别蛋白在细菌败血症中的作用最近已经被确定。这两者也被联系在一起
对病毒的免疫反应。利用转基因细胞系和可用的基因敲除小鼠
这些蛋白质影响细胞因子的初始诱导以及随后的
将定义对LCMV和埃博拉病毒的免疫反应。特定的TLR(和其他“模式”
识别蛋白“)参与这些反应以及它们之间的相互作用。
这些对长期带状T细胞免疫的早期识别事件将被调查。这些研究将
从而更好地理解先天免疫系统在调节
出血热病毒的病理生理学,并应导致新的治疗方法
疾病。
英文摘要
This project will examine the role of the innate immune system in the pathophysiology of the viral
hemorrhagic fevers. Two viruses which are potential agents of bioterrorism, will be studied: 1) Ebola virus, a
filovirus, which induces an acute illness characterized by fever, leucopenia, shock, and death, and 2)
Lymphocytic Choriomeningitis Virus LCMV an arenavirus which causes an illness characterized by
leucopenia and thrombocytopenia in mice and meningitis in humans. The high mortality rate associated with
Ebola infection has-been demonstrated to be directly associated with cytokine release which occurs after viral
infection of macrophages. The mechanism by which Ebola induces this cytokine response will be defined and
compounds will be screened for their ability to inhibit this activity. Preliminary data indicate a major role for
Toll Like Receptor 2 (TLR-2) and CD14 in the cytokine response to LCMV. TLR-2 and CD14 are pattern
recognition proteins whose role in bacterial sepsis has been recently defined. Both have also been associated
with the immune responses to viruses. Using transfected cell lines and available knockout mice the
mechanism by which these proteins affect both initial induction of cytokines as well as the subsequent
immune responses to LCMV and Ebola virus will be defined. The specific TLRs (and other "pattern
recognition proteins") involved in these responses as well as their interactions will be studied. The effect of
these early recognition events on long-term Band T cell immunity will be investigated. These studies will
result in a better understanding of the role that the innate immune system has in mediating the
pathophysiology of hemorrhagic fever viruses and should lead to new therapeutic approaches to these
diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
International Immunocompromised Host Society's 19th International Symposium on Infections in the Immunocompromised Host
-
批准号:9260163
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2016
-
负责人:Robert William Finberg
-
依托单位:
18th International Symposium on Infections in the Immunocompromised Host
-
批准号:8720337
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2014
-
负责人:Robert William Finberg
-
依托单位:
17th International Symposium on Infections in the Immunocompromised Host
-
批准号:8330069
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2012
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity Hemorrhagic fever viruses
-
批准号:8233435
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2011
-
负责人:Robert William Finberg
-
依托单位:
Toll2011 Meeting, Decoding Innate Immunity
-
批准号:8130053
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2011
-
负责人:Robert William Finberg
-
依托单位:
16th Symposium on Infections in the Immunocompromised Host
-
批准号:7994945
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2010
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity Hemorrhagic fever viruses
-
批准号:7669766
-
项目类别:
-
资助金额:$43.74万
-
财政年份:2009
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogensis
-
批准号:7877330
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2009
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Infection
-
批准号:7914345
-
项目类别:
-
资助金额:$182.82万
-
财政年份:2009
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Infection
-
批准号:7695247
-
项目类别:
-
资助金额:$185.64万
-
财政年份:2009
-
负责人:Robert William Finberg
-
依托单位:
Pathogenesis of myocarditis
-
批准号:7229933
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2006
-
负责人:Robert William Finberg
-
依托单位:
Pathogenesis of myocarditis
-
批准号:7030183
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2006
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:7389553
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:7578327
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:7190470
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogensis
-
批准号:7025825
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:6903196
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Cellular Immunity to Category A-C Viruses in Humans
-
批准号:8243671
-
项目类别:
-
资助金额:$314.38万
-
财政年份:2003
-
负责人:Robert William Finberg
-
依托单位:
Cellular Immunity to Category A-C Viruses in Humans
-
批准号:8452136
-
项目类别:
-
资助金额:$295.52万
-
财政年份:2003
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and LCMV
-
批准号:6711613
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2003
-
负责人:Robert William Finberg
-
依托单位:
海外基金